Janssen to Highlight Latest Research on Multiple Sclerosis at ACTRIMS Forum 2021
Janssen to Highlight Latest Research on Multiple Sclerosis at ACTRIMS Forum 2021 News provided by Share this article Share this article TITUSVILLE, N.J., Feb. 24, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that its latest multiple sclerosis (MS) research will be presented at the 2021 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum from February 25-27. Nine Janssen-sponsored data abstracts on MS research will be presented, including real-world evidence highlighting the impact of fatigue in U.S. adults with ...
Source: prnewswire.com